×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
EW – edwards lifesciences corporation (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
EW
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/19
07:22 am
ew
Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences [Yahoo! Finance]
Low
Report
Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences [Yahoo! Finance]
2/19
07:05 am
ew
Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences
Low
Report
Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences
2/16
08:21 am
ew
Edwards Lifesciences Corporation (NYSE:EW) is a favorite amongst institutional investors who own 88% [Yahoo! Finance]
Low
Report
Edwards Lifesciences Corporation (NYSE:EW) is a favorite amongst institutional investors who own 88% [Yahoo! Finance]
2/15
06:57 am
ew
Edwards Lifesciences Corporation (EW) Draws Positive Analyst View After Q4 Update [Yahoo! Finance]
Low
Report
Edwards Lifesciences Corporation (EW) Draws Positive Analyst View After Q4 Update [Yahoo! Finance]
2/13
07:23 am
ew
Edwards Lifesciences to Present at Citi's 2026 Unplugged Medtech and Life Sciences Access Day [Yahoo! Finance]
Low
Report
Edwards Lifesciences to Present at Citi's 2026 Unplugged Medtech and Life Sciences Access Day [Yahoo! Finance]
2/13
07:05 am
ew
Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day
Low
Report
Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day
2/12
12:26 pm
ew
Halper Sadeh LLC Encourages Edwards Lifesciences Corporation Shareholders to Contact the Firm to Discuss Their Rights
Low
Report
Halper Sadeh LLC Encourages Edwards Lifesciences Corporation Shareholders to Contact the Firm to Discuss Their Rights
2/11
10:58 am
ew
Edwards Lifesciences (NYSE:EW) was given a new $89.00 price target on by analysts at Truist Financial Corporation.
Low
Report
Edwards Lifesciences (NYSE:EW) was given a new $89.00 price target on by analysts at Truist Financial Corporation.
Date
Time
Symbol
Company Name
Action
%Chg
2/10/2026
04:15 pm
EW
edwards lifesciences corporation
MISS
Report
4.1%
edwards lifesciences corporation
10/30/2025
04:13 pm
EW
edwards lifesciences corporation
BEAT
Report
-1.2%
edwards lifesciences corporation
7/24/2025
04:15 pm
EW
edwards lifesciences corporation
BEAT
Report
5.5%
edwards lifesciences corporation
4/23/2025
04:15 pm
EW
edwards lifesciences corporation
BEAT
Report
6.6%
edwards lifesciences corporation
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/23
05:09 pm
ew
Form 4 Edwards Lifesciences For: Feb 22 Filed by: Lippis Daniel J.
Low
Report
Form 4 Edwards Lifesciences For: Feb 22 Filed by: Lippis Daniel J.
2/23
05:09 pm
ew
Form 4 Edwards Lifesciences For: Feb 22 Filed by: Dahl Andrew M.
Low
Report
Form 4 Edwards Lifesciences For: Feb 22 Filed by: Dahl Andrew M.
2/17
05:16 pm
ew
Form 4 Edwards Lifesciences For: Feb 12 Filed by: Lippis Daniel J.
Low
Report
Form 4 Edwards Lifesciences For: Feb 12 Filed by: Lippis Daniel J.
2/17
05:16 pm
ew
Form 4 Edwards Lifesciences For: Feb 16 Filed by: Ullem Scott B.
Low
Report
Form 4 Edwards Lifesciences For: Feb 16 Filed by: Ullem Scott B.
2/13
05:37 pm
ew
Form 4 Edwards Lifesciences For: Feb 12 Filed by: Zovighian Bernard J
Medium
Report
Form 4 Edwards Lifesciences For: Feb 12 Filed by: Zovighian Bernard J
2/12
04:54 pm
ew
Form 144 Edwards Lifesciences Filed by: Zovighian Bernard J
Low
Report
Form 144 Edwards Lifesciences Filed by: Zovighian Bernard J
2/10
04:23 pm
ew
Form 8-K Edwards Lifesciences For: Feb 10
Low
Report
Form 8-K Edwards Lifesciences For: Feb 10
1/12
11:26 am
ew
Form 8-K Edwards Lifesciences For: Jan 09
Low
Report
Form 8-K Edwards Lifesciences For: Jan 09
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/23
Form 4 Edwards Lifesciences For: Mar 23 Filed by: Szyman Catherine M.
17.6%
7/23 Q2/2019 6/30/2019 EPS 1.380 ZacksConsensus 1.320 ActVsEst 0.060 - Beat 9.8%
4/1 Form 4 Edwards Lifesciences For: Apr 01 Filed by: Lemercier Jean-Luc M 6.9%
3/9 Form 4 Edwards Lifesciences For: Mar 06 Filed by: BOBO DONALD E JR 6.2%
4/16 Form 4 Edwards Lifesciences For: Apr 16 Filed by: Szyman Catherine M. 5.0%
4/13 Form DEFA14A Edwards Lifesciences 4.9%
3/25 Form DEFA14A Edwards Lifesciences 4.5%
4/9 Edwards Lifesciences Corp (NYSE: EW) had its price target lowered by analysts at Raymond James from $263.00 to $230.00. They now have an "outperform" rating on the stock. 4.1%
10/25 Form 10-Q Edwards Lifesciences For: Sep 30 4.0%
2/3 Form 4 Edwards Lifesciences For: Feb 03 Filed by: Lemercier Jean-Luc M 3.7%
7/23 Q2/2019 6/30/2019 EPS 1.380 ZacksConsensus 1.320 ActVsEst 0.060 - Beat 9.8%
4/1 Form 4 Edwards Lifesciences For: Apr 01 Filed by: Lemercier Jean-Luc M 6.9%
3/9 Form 4 Edwards Lifesciences For: Mar 06 Filed by: BOBO DONALD E JR 6.2%
4/16 Form 4 Edwards Lifesciences For: Apr 16 Filed by: Szyman Catherine M. 5.0%
4/13 Form DEFA14A Edwards Lifesciences 4.9%
3/25 Form DEFA14A Edwards Lifesciences 4.5%
4/9 Edwards Lifesciences Corp (NYSE: EW) had its price target lowered by analysts at Raymond James from $263.00 to $230.00. They now have an "outperform" rating on the stock. 4.1%
10/25 Form 10-Q Edwards Lifesciences For: Sep 30 4.0%
2/3 Form 4 Edwards Lifesciences For: Feb 03 Filed by: Lemercier Jean-Luc M 3.7%
TOP News Decliners
1/30
Form 8-K Edwards Lifesciences For: Jan 30
-10.6%
4/24 Edwards Lifesciences Corp (NYSE: EW) had its "buy" rating re-affirmed by analysts at Citigroup Inc. They now have a $255.00 price target on the stock, up previously from $240.00. -5.7%
3/20 Form 4 Edwards Lifesciences For: Mar 19 Filed by: MUSSALLEM MICHAEL A -5.1%
4/27 Edwards Lifesciences Corp (NYSE: EW) had its "underweight" rating re-affirmed by analysts at Barclays PLC. They now have a $155.00 price target on the stock, down previously from $165.00. -5.0%
10/24 Edwards Lifesciences Corp (NYSE: EW) had its "overweight" rating re-affirmed by analysts at Piper Jaffray Companies. They now have a $255.00 price target on the stock, up previously from $240.00. -4.0%
4/28 Edwards Lifesciences Corp (NYSE: EW) was downgraded by analysts at Wells Fargo & Co from an "overweight" rating to an "equal weight" rating. -3.5%
4/30 Form 4 Edwards Lifesciences For: Apr 30 Filed by: Szyman Catherine M. -3.1%
3/30 Form 4 Edwards Lifesciences For: Mar 30 Filed by: WANG HUIMIN -3.0%
9/6 Form 4 Edwards Lifesciences For: Sep 06 Filed by: BOBO DONALD E JR -2.7%
3/2 Form 4 Edwards Lifesciences For: Mar 02 Filed by: Wood Larry L -2.5%
4/24 Edwards Lifesciences Corp (NYSE: EW) had its "buy" rating re-affirmed by analysts at Citigroup Inc. They now have a $255.00 price target on the stock, up previously from $240.00. -5.7%
3/20 Form 4 Edwards Lifesciences For: Mar 19 Filed by: MUSSALLEM MICHAEL A -5.1%
4/27 Edwards Lifesciences Corp (NYSE: EW) had its "underweight" rating re-affirmed by analysts at Barclays PLC. They now have a $155.00 price target on the stock, down previously from $165.00. -5.0%
10/24 Edwards Lifesciences Corp (NYSE: EW) had its "overweight" rating re-affirmed by analysts at Piper Jaffray Companies. They now have a $255.00 price target on the stock, up previously from $240.00. -4.0%
4/28 Edwards Lifesciences Corp (NYSE: EW) was downgraded by analysts at Wells Fargo & Co from an "overweight" rating to an "equal weight" rating. -3.5%
4/30 Form 4 Edwards Lifesciences For: Apr 30 Filed by: Szyman Catherine M. -3.1%
3/30 Form 4 Edwards Lifesciences For: Mar 30 Filed by: WANG HUIMIN -3.0%
9/6 Form 4 Edwards Lifesciences For: Sep 06 Filed by: BOBO DONALD E JR -2.7%
3/2 Form 4 Edwards Lifesciences For: Mar 02 Filed by: Wood Larry L -2.5%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: